Letter to the Editor
Real-world outcomes of chemotherapy in pancreatic cancer: considerations for validity and interpretation
Annals of Pancreatic Cancer
2026;
9:
7
.
(30 January 2026)
Letter to the Editor
Improving long-term outcomes in resectable pancreatic cancer
Annals of Pancreatic Cancer
2026;
9:
6
.
(30 January 2026)
Original Article
Estimation of symptoms burden in advanced pancreatic cancer patient and impact of palliative care intervention on it
Annals of Pancreatic Cancer
2026;
9:
5
.
(30 January 2026)
Editorial Commentary
Optimal management of resectable pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2026;
9:
4
.
(30 January 2026)
Letter to the Editor
FOLFIRINOX for pancreatic cancer: a real-world registry analysis
Annals of Pancreatic Cancer
2026;
9:
3
.
(30 January 2026)
Editorial Commentary
Defining risk-adapted adjuvant therapy in resectable pancreatic cancer: an editorial commentary on long-term outcomes from ESPAC4
Annals of Pancreatic Cancer
2026;
9:
2
.
(30 January 2026)
Editorial Commentary
ESPAC-4 long-term follow-up: shall we choose gemcitabine and capecitabine as adjuvant therapy for elderly and low-risk pancreatic adenocarcinoma following surgical resection?
Annals of Pancreatic Cancer
2026;
9:
1
.
(30 January 2026)
Editorial Commentary
Insights from the NEOPAN trial: FOLFIRINOX vs. gemcitabine in locally advanced pancreatic cancer
Annals of Pancreatic Cancer
2025;
8:
15
.
(30 October 2025)
Case Report
Pancreatic adenocarcinoma with metastasis to cervix: a case report of an unusual neoplastic demeanor
Annals of Pancreatic Cancer
2025;
8:
14
.
(30 October 2025)
Original Article
Efficacy and toxicity of gemcitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma after disease progression on FOLFIRINOX: a single-center analysis
Annals of Pancreatic Cancer
2025;
8:
13
.
(30 September 2025)
Editorial Commentary
Another chapter in the tale of FOLFIRINOX in the management of pancreatic ductal adenocarcinoma: do the results in the locally advanced setting fall short of expectations?
Annals of Pancreatic Cancer
2025;
8:
12
.
(30 September 2025)
Brief Report
Concordance between preoperative imaging and surgical specimen size in the evaluation of intraductal papillary mucinous neoplasms of the pancreas
Annals of Pancreatic Cancer
2025;
8:
11
.
(30 August 2025)
Letter to the Editor
Cabozantinib in well-differentiated metastatic pancreatic neuroendocrine tumors: a promising addition to the therapeutic arsenal
Annals of Pancreatic Cancer
2025;
8:
10
.
(30 August 2025)
Original Article
Exploring the link between pancreatic cancer and key risk factors: insights from decade-long study in Eastern Algeria
Annals of Pancreatic Cancer
2025;
8:
9
.
(30 July 2025)
Original Article
FOLFIRINOX versus gemcitabine (plus paclitaxel) for pancreatic cancer—an analysis based on data from the Clinical Cancer Registry of Lower Saxony
Annals of Pancreatic Cancer
2025;
8:
8
.
(30 July 2025)
Original Article
Treatment and prophylaxis of thromboembolism in pancreatic cancer: influence on patient survival in western Algeria
Annals of Pancreatic Cancer
2025;
8:
7
.
(30 July 2025)
Original Article
Identification and assessment of ferroptosis-related genes and their implication as therapeutic agents for pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2025;
8:
6
.
(30 July 2025)
Case Series
Duodenal aspiration biopsy for diagnosing pancreatic cystic lesions: a four-case series
Annals of Pancreatic Cancer
2025;
8:
5
.
(30 July 2025)
Review Article
The role of alcohol as a risk factor in pancreatic cancer: a systematic review based on cohort and case-control studies
Annals of Pancreatic Cancer
2025;
8:
4
.
(30 July 2025)
Original Article
Combination of axial and bivalve techniques in the grossing protocol for pancreaticoduodenectomy specimens in the assessment of ampullary and pancreatic adenocarcinomas and intraductal papillary mucinous neoplasia
Annals of Pancreatic Cancer
2025;
8:
3
.
(30 May 2025)
Case Report
Clear cell carcinoma of the pancreas: a case report of a not so clear disease
Annals of Pancreatic Cancer
2025;
8:
2
.
(30 March 2025)
Review Article
Bibliometric review of journal articles on pancreatic cancer: insights into productivity and impact
Annals of Pancreatic Cancer
2025;
8:
1
.
(30 March 2025)
Original Article
Synthesis and evaluation of novel pyrimidine derivative targeting pancreatic adenocarcinoma
Annals of Pancreatic Cancer
2024;
7:
11
.
(31 October 2024)
Original Article
Diagnostic precision of endoscopic ultrasound versus contrast-enhanced computed tomography in detection of vascular involvement in pancreatic and periampullary cancers as compared to surgery
Annals of Pancreatic Cancer
2024;
7:
10
.
(31 October 2024)
Case Report
Visceral crisis in a patient with pancreatic ductal adenocarcinoma with DPYD and UGT1A1 gene mutations: case report, literature review, and viewpoint
Annals of Pancreatic Cancer
2024;
7:
9
.
(31 October 2024)